Back to
CITADEL ADVISORS LLC
RVNCShowing 3 of 26 quarters
Position history for
CITADEL ADVISORS LLC's holdings in REVANCE THERAPEUTICS INC
As of its Q4 2024 13F, Citadel Advisors held 91,118 shares of RVNC (Revance Therapeutics), worth $276,999.
Final Value
$0
Final Shares
0
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of RVNC: Capital World Investors